Korean Journal of Pharmacognosy (생약학회지)

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Neuroprotective Effects of Herbal Ethanol Extracts from Gynostemma pentaphyllum on L-DOPA Therapy in 6-hydroxydopamine-lesioned Rat Model of Parkinson's Disease

돌외 에탄올 추출물 엑스가 6-hydroxydopamine-유도 파킨슨병 백서 모델에서의 L-DOPA 요법에 미치는 영향

  • Received : 2011.10.31
  • Accepted : 2011.12.15
  • Published : 2011.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

The neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum (GP-EX) in 6-hydroxydopamine (6-OHDA)-lesioned rat model of Parkinson's disease treated with L-DOPA were investigated. Rats were prepared for the Parkinson's disease model by 6-OHDA-lesioning for 14 days. The rats were then treated with L-DOPA (10 and 20 mg/kg) with or without the oral administration of GP-EX (30 mg/kg, daily) for 28 days. L-DOPA (20 mg/kg) treatment for 28 days enhanced dopaminergic neuronal cell death in 6-OHDA-lesioned rat groups, but L-DOPA (10 mg/kg) did not. However, the oral administration of GP-EX (30 mg/kg) for 28 days ameliorated the enhanced neurotoxic effects induced by chronic L-DOPA treatment in 6-OHDA-lesioned rat groups by increasing tyrosine hydroxylase (TH)-immunohistochemical staining and the number of TH-immunopositive cells surviving in the substantia nigra. In addition, GP-EX administration (30 mg/kg) for 28 days recovered the levels of dopamine and norepinephrine of the striatum in 6-OHDA-lesioned rat groups, which were markedly reduced by L-DOPA treatment (20 mg/kg). GP-EX (30 mg/kg) did not produce any signs of toxicity, such as weight loss, diarrhea, or vomiting in rats during the 28-day treatment period. These results suggest that GP-EX has protective functions against chronic L-DOPA-induced neurotoxic reactions in dopaminergic neurons in the 6-OHDA-lesioned rat model of Parkinson's disease. Therefore, GP-EX may be beneficial in the prevention of adverse symptoms in parkisonian patients.

Keywords

References

  1. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A. and Mucke, L. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287: 1265-1269. https://doi.org/10.1126/science.287.5456.1265
  2. Hatano, T., Kubo, S., Sato, S. and Hattori, N. (2009) Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. J. Neurochem. 111: 1075-1093. https://doi.org/10.1111/j.1471-4159.2009.06403.x
  3. Joh, T. H., Park, D. H. and Reis, D. J. (1978) Direct phosphorylation of brain tyrosine hydroxylase by cyclic AMP dependent protein kinase: mechanism of enzyme activation. Proc. Natl. Acad. Sci. USA 75: 4744-4748. https://doi.org/10.1073/pnas.75.10.4744
  4. Young, E. A., Duchemin, A.-M., Neff, N. H. and Hadjiconstantinou, M. (1998) Parallel modulation of striatal dopamine synthetic enzymes by second messenger pathways. Eur. J. Pharmacol. 357: 15-23. https://doi.org/10.1016/S0014-2999(98)00497-X
  5. Graham, D. G. (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14: 633-643.
  6. Ziv, I., Zilkha-Falb, R., Offen, D., Shirvan, A., Barzilai, A. and Melamed, E. (1997) Levodopa induces apoptosis in cultured neuronal cells: a possible accelerator of nigrostriatal degeneration in Parkinson's disease? Mov. Disord. 12: 17-23. https://doi.org/10.1002/mds.870120105
  7. Cheng, N., Maeda, T., Kume, T., Kaneko, S., Kochiyama, H., Akaike, A., Goshima, Y. and Misu, Y. (1996) Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res. 743: 278-283. https://doi.org/10.1016/S0006-8993(96)01056-6
  8. Yacoubian, T. A. and Standaert, D. C. (2009) Targets for neuroprotection in Parkinson's disease. Biochim. Biophys. Acta 1792: 676-687. https://doi.org/10.1016/j.bbadis.2008.09.009
  9. Bowers, W. J., Howard, D. F. and Federoff, H, J. (1997) Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease. Exp. Neurol. 144: 58-68. https://doi.org/10.1006/exnr.1996.6389
  10. Razmovski-Naumovski, V., Huang, T. H. W., Tran, V. H., Li, G. Q., Duke, C. C. and Roufogalis, B. D. (2005) Chemistry and pharmacology of Gynostemma pentaphyllum. Phytochem. Review 4: 197-210. https://doi.org/10.1007/s11101-005-3754-4
  11. Choi, H. S., Lim, S. A., Park, M. S., Hwang B. Y., Lee, C. K., Kim, S. H., Lin, S. C. and Lee, M. K. (2008) Ameliorating effects of the ethanol extracts from Gynostemma pentaphyllum on electric footshock stress. Kor. J. Pharmacogn. 39: 341-346.
  12. Im, S. A., Choi, H. S., Hwang, B. Y., Lee, M. K. and Lee, C. K. (2009) Augmentation of immune responses by oral administration of Gynostemma pentaphyllum ethanol extract. Kor. J. Pharmacogn. 40: 35-40.
  13. Choi, H. S., Shin, K. S., Choi, S. O., Kim, S. H., Lee, C. K., and Lee, M. K. (2011) Ameliorating effects of herbal ethanol extract from Gynostemma pentaphyllum on chronic stressinduced anxiety in mice. Kor. J. Pharmacogn. 42: 32-37.
  14. Choi, H. S. Park, M. S., Kim, S. H., Hwang, B. Y., Lee, C. K. and Lee, M. K. (2010). Neuroprotective effects of herbal ethanol extracts from Gynostemma pentaphyllum in the 6- hydroxydopamine-lesioned rat model of Parkinson's disease. Molecules 15: 2814-2824. https://doi.org/10.3390/molecules15042814
  15. Borah, A. and Mohanakumar, K. P. (2009) Long term LDOPA treatment causes production of 6-OHDA in the mouse striatum: Involvement of hydroxyl radical. Ann. Neurosci. 16: 160-165.
  16. Schober, A. (2004) Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 318: 215-224. https://doi.org/10.1007/s00441-004-0938-y
  17. Paxinos, G. and Watson, C. (1986) The rat brain in stereotaxic coordinates. 2nd ed., Academic Press, Australia.
  18. Lee, C. S., Sauer, H. and Bjorklund, A. (1996) Dopaminergic neuronal degeneration and motor impairments following axonterminal lesion by intrastriatal 6-hydroxydopamine in rats. Neuroscience 72: 641-653. https://doi.org/10.1016/0306-4522(95)00571-4
  19. Lee, J. J., Kim, Y. M., Yin, W. Y., Park, H. D., Kang, M. H., Hong, J. T. and Lee, M. K. (2003) Aggravation of L-DOPAinduced neurotoxicity by tetrahydropapaveroline in PC12 cells. Biochem. Pharmacol. 66: 1787-1795. https://doi.org/10.1016/S0006-2952(03)00421-0
  20. Saurer, H. and Oertel, W.H. (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59(2): 401-415. https://doi.org/10.1016/0306-4522(94)90605-X
  21. Sotelo, C., Javoy, F., Agid, T. and Glwinski, J. (1973) Injcetion of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphological study. Brain Res. 58: 269-290. https://doi.org/10.1016/0006-8993(73)90001-2
  22. Melamed, E,, Offen, D., Shirvan, A., Djaldetti, R., Barzilai, A. and Ziv, I. (1998) Levodopa toxicity and apoptosis. Ann. Neurol. 44: S149-154.
  23. Nagatsu, T. (1997). Isoquinoline neurotoxins in the brain and Parkinson's disease, Neurosci. Res. 29: 99-111. https://doi.org/10.1016/S0168-0102(97)00083-7
  24. Borah, A. and Mohanakumar, K.P. (2009) L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation. Neurochem. Int. 56: 357-362.
  25. Mura, A., Mintz, M. and Feldon, J. (2002) Behavioral and anatomical effects of long-term L-dihydroxyphenylalanine (L-DOPA) administration in rats with unilateral lesions of the nigrostriatal system. Exp. Neurol. 177: 252-264. https://doi.org/10.1006/exnr.2002.7976
  26. Shang, L., Liu, J,. Zhu, Q., Zhao, L., Feng Y., Wang, X. Cao, W. and Xin, H. (2006) Gypenosides protect primary cultures of rat cortical cells against oxidative neurotoxicity. Brain Res. 1102: 163-174. https://doi.org/10.1016/j.brainres.2006.05.035
  27. Wang, P., Niu, L., Gao, L., Li, W. X., Jia, D., Wang, X. L. and Gao, G. D. (2010) Neuroprotective effect of gypenosides against oxidative injury in the substantia nigra of a mouse model of Parkinson's disease. J. Int. Med. Res. 38: 1084- 1092. https://doi.org/10.1177/147323001003800336
  28. Attawish, A., Chivapat, S., Phadungpat, S., Bansiddhi, J., Techadamrongsin, Y., Mitrijit, O., Chaorai, B. and Chavalittumrong, P. (2004) Chronic toxicity of Gynostemma pentaphyllum. Fitoterapia 75: 539-551. https://doi.org/10.1016/j.fitote.2004.04.010
  29. Jeong, S. H., Lee, M. K., Park, M. S. and Kim, J. M. (2011) Randomized, double-blind study of efficacy and safety of Gynostemma pentaphyllum ethanol extract in a normal population. Kor. J. Clin. Pharm. 21: 131-137.
  30. Chaturvedi, R, K., Shukla, S., Seth, K., Chauhan, S., Sinha, C., Shukla, Y. and Agrawal, A. K. (2006) Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine- lesioned rat model of Parkinson's disease. Neurobiol. Dis. 22: 421-434. https://doi.org/10.1016/j.nbd.2005.12.008
  31. Bae, N., Ahn, T., Chung, S., Oh, M. S., Ko, H., Oh, H., Park, G. and Yang H. O. (2010) The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease. J. Ethnopharmacol. 134: 313-322.